Current filters:  
Canada
IP
Canada
Norton Rose Fulbright Canada LLP
L'obtention de brevets dans la République populaire de Chine (RPC) demeure un objectif important pour les entreprises pharmaceutique nord-américaines.
Oyen Wiggs Green & Mutala LLP
On 17 February 2021, Conservative Senator Claude Carignan introduced a private members bill, S-225, "An Act to amend the Copyright Act (remuneration for journalistic works)".
Torys LLP
According to the Canada-United States-Mexico Agreement (CUSMA)1, Canadian patent applications filed on or after December 1, 2020.
Bereskin & Parr LLP
Sheryl Crow sang "a change will do you good", and it's clear that the desire for changes to be made to Canada's Copyright Act (the "Act") are in the air.
Aird & Berlis LLP
In Canada, it has long been understood that when it comes to the construction of claims in a patent litigation matter
Norton Rose Fulbright Canada LLP
Last week, in Hidden Bench Vineyards & Winery Inc. v. Locust Lane Estate Winery Corp., 2021 FC 156, the Federal Court dismissed an application by Hidden Bench Vineyards & Winery Inc. seeking a declaration that it is the owner of the unregistered trademark "LOCUST LANE".
Smart & Biggar
On December 22, 2020, the Federal Court issued its decision holding that section 8.2 of the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations)...
Smart & Biggar
As reported previously here, the Federal Court had found that Kennedy's patent for infliximab (Janssen's REMICADE) was valid and infringed by Hospira's biosimilar INFLECTRA ("Trial Decision").
Gowling WLG
Amid the frenetic pace of today's innovation lifecycle, do patents always afford the best protection of proprietary inventions?
Bereskin & Parr LLP
The Federal Court recently released an important decision addressing for the first time the timeline that governs the right of action for "unlisted" patents under section 8.2 of the...
Bereskin & Parr LLP
On February 17, 2021, Senator Claude Carignan introduced a private members Bill in the Canadian Senate. The Bill, S-225 An Act to amend the Copyright Act (remuneration for journalistic works),...
Bereskin & Parr LLP
Il peut être délicat de conseiller les clients qui n'en sont qu'aux premières étapes de la création d'une entreprise.
Bereskin & Parr LLP
Les diagnostics et certains types d'inventions utilisant l'intelligence artificielle (IA) (de même que certaines autres inventions mises en œuvre par ordinateur)...
Bereskin & Parr LLP
Le plan du gouvernement fédéral visant à réduire davantage les prix des médicaments au Canada suscite une grande controverse.
Bereskin & Parr LLP
L'année 2020 a vu d'importants développements en matière de brevetabilité des inventions mises en œuvre par ordinateur.
Bereskin & Parr LLP
2020 a certes été marquée par les bouleversements causés par la pandémie de COVID-19.
Bereskin & Parr LLP
Suite à la ratification du Traité sur le droit des brevets par le Canada, de nouvelles Règles sur les brevets (ci-après « les Règles ») sont entrées en vigueur le 30 octobre 2019...
Norton Rose Fulbright Canada LLP
The Tragically Hip (The Hip) is suing Mill Street Brewery (Mill Street) over "100th Meridian" Beer. The action was commenced in the Federal Court by Statement of Claim dated February 9, 2021
Gowling WLG
In the recently issued decision, Merck Sharp & Dohme Corp. v. Sandoz Canada Inc. (2020 FC 1180) Justice Southcott confirmed that a 45-day...
Osler, Hoskin & Harcourt LLP
For nearly 30 years, pharmaceutical patent policy in Canada has been designed to strike a balance between rewarding pharmaceutical innovation and enabling affordable drug access.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media